Get the Stockscreener App
10.75
3.27%
0.34
After Hours:
10.32
-0.43
-4.00%
Orthofix Medical Inc stock is traded at $10.75, with a volume of 834.62K.
It is up +3.27% in the last 24 hours and down -11.45% over the past month.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
See More
Previous Close:
$10.41
Open:
$10.11
24h Volume:
834.62K
Relative Volume:
2.60
Market Cap:
$434.53M
Revenue:
$825.37M
Net Income/Loss:
$-60.01M
P/E Ratio:
-7.1566
EPS:
-1.5021
Net Cash Flow:
$-4.46M
1W Performance:
-10.49%
1M Performance:
-11.45%
6M Performance:
-29.55%
1Y Performance:
-4.27%
1-Day Range:
$10.11
$11.00
1-Week Range:
$9.50
$12.53
52-Week Range:
$9.50
$16.99
Orthofix Medical Inc Stock (OFIX) Company Profile
Name
Orthofix Medical Inc
Sector
Industry
Phone
214-937-2000
Address
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
10.75 | 420.79M | 825.37M | -60.01M | -4.46M | -1.5021 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Hold |
| Oct-28-25 | Resumed | Stifel | Buy |
| Jan-22-25 | Initiated | Canaccord Genuity | Buy |
| Nov-08-24 | Upgrade | Stifel | Hold → Buy |
| May-08-24 | Upgrade | ROTH MKM | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Sep-12-23 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-12-23 | Downgrade | Stifel | Buy → Hold |
| Jul-19-23 | Resumed | BTIG Research | Buy |
| Mar-04-22 | Upgrade | Stifel | Hold → Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Oct-29-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Jun-14-17 | Initiated | Ladenburg Thalmann | Buy |
| May-23-17 | Initiated | SunTrust | Buy |
| Jul-10-15 | Initiated | Sidoti | Buy |
| May-09-13 | Downgrade | Mizuho | Buy → Neutral |
| Jan-08-13 | Reiterated | Mizuho | Buy |
| Jun-21-10 | Initiated | Boenning & Scattergood | Outperform |
| Mar-09-10 | Reiterated | Jefferies & Co | Buy |
| Feb-18-10 | Upgrade | Susquehanna Financial | Neutral → Positive |
| Jan-22-10 | Initiated | Jefferies & Co | Buy |
| Nov-03-09 | Upgrade | Wells Fargo | Underperform → Market Perform |
| Jul-31-09 | Reiterated | Jefferies & Co | Buy |
| Jul-31-09 | Upgrade | Thomas Weisel | Market Weight → Overweight |
| May-26-09 | Reiterated | Jefferies & Co | Buy |
| Apr-17-09 | Downgrade | Wachovia | Mkt Perform → Underperform |
| Feb-19-09 | Initiated | Canaccord Adams | Buy |
| Jul-07-08 | Downgrade | Wachovia | Outperform → Mkt Perform |
View All
Orthofix Medical Inc Stock (OFIX) Latest News
Discipline and Rules-Based Execution in OFIX Response - Stock Traders Daily
Orthofix lowers outlook on Medicare changes to bone growth stimulators - MSN
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
OFIX Maintains Rating by Barrington Research -- Price Target Low - GuruFocus
Barrington Adjusts Price Target on Orthofix Medical to $15 From $17, Maintains Outperform Rating - Moomoo
Stifel cuts Orthofix Medical stock price target on reimbursement hit - Investing.com
Stifel cuts Orthofix Medical stock price target on reimbursement hit By Investing.com - Investing.com Nigeria
TD Cowen cuts Orthofix Medical stock price target on CMS rate cuts By Investing.com - Investing.com South Africa
TD Cowen cuts Orthofix Medical stock price target on CMS rate cuts - Investing.com UK
Canaccord cuts Orthofix Medical stock price target on reimbursement headwinds By Investing.com - Investing.com South Africa
Canaccord cuts Orthofix Medical stock price target on reimbursement headwinds - Investing.com Australia
Orthofix (OFIX) Faces Financial Outlook Adjustment Following FDA Reclassification - GuruFocus
OrthoFix Medical Withdraws Three-Year Financial Targets Following FDA Reclassification and CMS Reimbursement Changes - Minichart
Orthofix (OFIX) Revises Financial Projections for Next Three Yea - GuruFocus
Orthofix (OFIX) Lowers FY Revenue Outlook, Shares Plunge - GuruFocus
OFIX Stock Drops in Morning Trading - GuruFocus
Orthofix Medical updates 2026 outlook following Medicare reimbursement changes By Investing.com - Investing.com South Africa
Orthofix Cuts 2026 Outlook After Medicare Reimbursement Changes - TipRanks
Orthofix Medical updates 2026 outlook following Medicare reimbursement changes - Investing.com
Orthofix Medical : Investor PresentationMay 21, 2026 - marketscreener.com
Orthofix Medical updates 2026 outlook after CMS Medicare cuts for bone growth stimulators - TradingView
Medicare cuts push Orthofix (NASDAQ: OFIX) to lower 2026 outlook and scrap 3-year goals - Stock Titan
Orthofix Medical Signals Gradual Turn in Earnings Call - TipRanks
Orthofix Medical Inc stock (US6875231068): spine specialist in focus after recent setbacks and restr - AD HOC NEWS
Orthofix to Participate in Upcoming Investor Conferences - Ortho Spine News
How The Orthofix Medical (OFIX) Investment Story Is Resetting After New Guidance And Targets - Yahoo Finance
Orthofix Medical Inc stock (US6875231068): spine specialist in focus after latest guidance and leade - AD HOC NEWS
Orthofix Medical Inc.Common Stock (NQ: OFIX - The Chronicle-Journal
Armistice Capital (OFIX) reports 2.7M shares, 6.73% stake in Orthofix - Stock Titan
Behavioral Patterns of OFIX and Institutional Flows - Stock Traders Daily
Orthofix Medical stock (US6875231068): Brokerages rate Hold with $17.25 target - AD HOC NEWS
Orthofix Medical Inc. (NASDAQ:OFIX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Bone Growth Stimulators Market to Reach US$ 2.70 Billion by 2033 - openPR.com
Orthofix reshuffles spine division leadership, posts preliminary Q1 sales - MSN
Insider Buying: HENNEMAN JOHN B III Acquires 5,000 Shares of Ort - GuruFocus
Orthofix (OFIX) director John Henneman buys 5,000 shares at $12.26 - Stock Titan
US$17.25: That's What Analysts Think Orthofix Medical Inc. (NASDAQ:OFIX) Is Worth After Its Latest Results - simplywall.st
Orthofix Medical Inc. (NASDAQ:OFIX) Just Reported, And Analysts Assigned A US$17.25 Price Target - Yahoo Finance
Orthofix Medical Inc. (OFIX) Stock Analysis: Evaluating The 42.92% Potential Upside - DirectorsTalk Interviews
Orthofix (OFIX) Unveils Innovations in Pediatric Limb Reconstruc - GuruFocus
Engine capital funds acquire $2.23m of Orthofix Medical shares By Investing.com - Investing.com South Africa
Orthofix Medical Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:OFIX) 2026-05-07 - Seeking Alpha
Engine capital funds acquire $2.23m of Orthofix Medical shares - Investing.com UK
Engine Capital (NASDAQ: OFIX) funds add 184,896 Orthofix Medical shares in open-market buys - Stock Titan
Orthofix (OFIX) Q1 2026 Earnings Transcript - AOL.com
Orthofix to Report First Quarter 2026 Financial Results - Quantisnow
Full Transcript: Orthofix Medical Q1 2026 Earnings Call - Sahm
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting - Orthopedics This Week
Orthofix Medical Inc Stock (OFIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):